Insider · CIK 0001688770
Kevin Comcowich
Files at RKDA (Arcadia Biosciences, Inc.). First filing -, latest -.
Kevin Comcowich files SEC Form 4 as director at RKDA (Arcadia Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kevin Comcowich has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | RKDA Arcadia Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +23,000 | $0.00 | $0 | 54,042 | 29 d ago |
Questions about Kevin Comcowich
Answered from the filings on this page, as of the latest one.
Is Kevin Comcowich buying or selling?
Kevin Comcowich has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kevin Comcowich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin Comcowich has 0.
Where does Kevin Comcowich file Form 4?
Kevin Comcowich has filed Form 4 at RKDA (Arcadia Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.